Sheng Yan

10PUBLICATIONS

20CO-AUTHORS

Molecular targetsSolid tumoursHaematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (10)

Sort by Publication Date:

|Jun 30, 2026

Inhibiting PPM1D Perturbs Mitochondrial Integrity to Stimulate cGAS-STING Signaling and Antitumor Immunity.

|May 20, 2026

The STK33/mTORC1/S6K1/HIF-1α signalling axis drives glycolysis and progression in pancreatic neuroendocrine tumours.

|Feb 27, 2026

The Molecular Network of Neutrophil Extracellular Traps in Hepatocellular Carcinoma: Biogenesis, Function, and Therapeutic Implications.

Chang Liu, Jienan Lu, Yang Tian

|Nov 24, 2025

IGF2BP3 regulates EMP1 stability in an m<sup>6</sup>A-dependent manner and activates the TGF-β pathway to promote pancreatic cancer invasion.

Long Liu, Yu Zhang, Yuxi Huang

|Jul 29, 2023

Development and Validation of a Nomogram for Preoperative Prediction of Early Recurrence after Upfront Surgery in Pancreatic Ductal Adenocarcinoma by Integrating Deep Learning and Radiological Variables.

Fei Xiang, Xiang He, Xingyu Liu

|Nov 07, 2022

FAM83A promotes the progression and metastasis of human pancreatic neuroendocrine tumors by inducing the epithelial-mesenchymal transition via the PI3K/AKT and ERK pathways.

B Zhou, X Zhou, C Zhan

Pageof 2

Frequent Collaborators

Sitong Zhang

Zhenzhen Gao

Yanjie Li

Xin Han

Qianhui Xu

Liuzhi Zhou

Yining Chen

Hao Xu

Yang Bai

Hao Ding

Frequent Collaborators

Sitong Zhang

Zhenzhen Gao

Yanjie Li

Xin Han